XML 76 R48.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Stock-Based Compensation [Abstract] |
Share-Based Payment Arrangement, Cost by Plan | Stock-based compensation expense for the years ended December 31, 2024, 2023 and 2022 is as follows:
| Year Ended December 31,
(in thousands) | 2024 |  | 2023 |  | 2022
Stock options | $ | 340 |  |  | $ | 900 |  |  | $ | 1,327 |
Restricted share units(1)(2) | 35,734 |  |  | 161,216 |  |  | 158,031 |
Total stock-based compensation expense | 36,074 |  |  | 162,116 |  |  | 159,358 |
Tax benefit recognized in the Consolidated Statements of Operations | 5,483 |  |  | 5,168 |  |  | 3,391 |
Stock-based compensation expense, net of tax | $ | 30,591 |  |  | $ | 156,948 |  |  | $ | 155,967 |
(1) Includes expense of $4.9 million, $137.5 million and $143.2 million for the years ended December 31, 2024, 2023 and 2022, respectively in stock compensation expense related to 8,096,595 common shares issued to the former owners of Acima, as part of the Aggregate Stock Consideration subject to restricted stock agreements, and recorded to Other gains and charges in our Consolidated Statements of Operations. Shares issued as part of the Aggregate Stock Consideration for the acquisition of Acima Holdings were not issued under the authorization of the 2021 Plan or any prior approved long-term incentive plan described above. See Note N for additional information. (2) Includes expense of $5.1 million for the year ended December 31, 2024 in stock compensation expense related to accelerated stock compensation due to the letter agreement entered into with the Company's Chief Executive Officer and recorded to Other gains and charges in our Consolidated Statements of Operations. See Note N for additional information.
Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity | Information with respect to stock option activity related to the Plans for the year ended December 31, 2024 follows:
| Equity Awards Outstanding |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life |  | Aggregate Intrinsic Value (in thousands)
Balance outstanding at January 1, 2024 | 655,643 |  |  | $ | 22.36 |  |  |  |  |
Granted | — |  |  | — |  |  |  |  |
Exercised | (73,152) |  |  | 24.59 |  |  |  |  |
Forfeited | (3,996) |  |  | 43.24 |  |  |  |  |
Expired | (15,501) |  |  | 36.38 |  |  |  |  |
Balance outstanding at December 31, 2024 | 562,994 |  |  | $ | 21.54 |  |  | 4.27 |  | $ | 4,886 |
Exercisable at December 31, 2024 | 550,602 |  |  | $ | 21.03 |  |  | 4.23 |  | $ | 4,891 |
Schedule of Nonvested Restricted Stock Units Activity | Information with respect to non-vested restricted stock unit activity follows:
| Restricted Awards Outstanding |  | Weighted Average Grant Date Fair Value
Balance outstanding at January 1, 2024(1) | 2,208,752 |  |  | $ | 37.10 |
Granted | 829,959 |  |  | 37.09 |
Vested(2) | (758,275) |  |  | 48.28 |
Forfeited | (207,614) |  |  | 57.99 |
Balance outstanding at December 31, 2024 | 2,072,822 |  |  | $ | 30.91 |
(1) Includes 363,791 outstanding shares at January 1, 2024 related to RSA agreements issued as part of the Aggregate Stock Consideration for the acquisition of Acima Holdings, which were not issued under the authorization of the 2021 Plan or any previously approved long-term incentive plan described above. These RSA were fully vested during the year ended December 31, 2024. (2) Includes 363,791 shares vested during 2024 as part of RSA agreements issued as part of the Aggregate Stock Consideration for the acquisition of Acima Holdings, as described above.

X
- Definition Stock Based Compensation. + References No definition available. + Details
Name: | upbd_StockBasedCompensationAbstract
Namespace Prefix: | upbd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration